MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, CBIO has $240,293K in assets. $37,281K in debts. $213,192K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
656.06%
Quick Ratio
656.06%
Cash Ratio
591.02%
Debt to Asset Ratio
15.51%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Accounts receivable, net
    • Prepaid expenses and other curre...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accrued expenses and other curre...
    • Others

Balance Sheets
2025-12-31
Cash and cash equivalents
213,192
Accounts receivable, net
18,000
Prepaid expenses and other current assets
5,463
Total current assets
236,655
Property and equipment, net
846
Operating lease right-of-use assets
1,469
Restricted cash
107
Other assets
1,216
Total assets
240,293
Accounts payable-Nonrelated Party
9,997
Accrued expenses and other current liabilities-Nonrelated Party
16,344
Related party accounts payable and other current liabilities-Related Party
140
Deposit liability
5,000
Deferred revenue
4,156
Operating lease liability, current
435
Warrant liability, related party
0
Total current liabilities
36,072
Operating lease liability, noncurrent
1,209
Notes payable, noncurrent
0
Total liabilities
37,281
Series a non-voting convertible preferred shares, 0.001 par value 2,890 shares and no shares authorized as of december 31, 2025 and december 31, 2024, respectively 2,890 shares and no shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively-Series APreferred Stock
4,000
Ordinary shares, 0.001 par value shares and 40,000,000 shares authorized as of december 31, 2025 and december 31, 2024, respectively and shares issued and outstanding as of december 31, 2025 and december 31, 2024, respectively
28
Additional paid-in capital
370,793
Accumulated deficit
-171,809
Total shareholders' equity (deficit)
203,012
Total liabilities, convertible preferred shares, and shareholders equity (deficit)
240,293
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$213,192K Accounts receivable, net$18,000K Prepaid expenses andother current assets$5,463K Total current assets$236,655K Operating leaseright-of-use assets$1,469K Other assets$1,216K Property and equipment,net$846K Restricted cash$107K Total assets$240,293K Total liabilities,convertible preferred...$240,293K Total shareholders'equity (deficit)$203,012K Total liabilities$37,281K Accumulated deficit-$171,809K Additional paid-in capital$370,793K Total currentliabilities$36,072K Operating leaseliability, noncurrent$1,209K Series a non-votingconvertible preferred...$4,000K Ordinary shares, 0.001par value shares and...$28K Accrued expenses andother current...$16,344K Accountspayable-Nonrelated Party$9,997K Deposit liability$5,000K Deferred revenue$4,156K Operating leaseliability, current$435K Related party accountspayable and other...$140K

CRESCENT BIOPHARMA, INC. (CBIO)

CRESCENT BIOPHARMA, INC. (CBIO)